COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: insight to the immune response after COVID

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: insight to the immune response after COVID
Authors
Keywords
Alemtuzumab, Coronavirus 2019, Multiple sclerosis, Reinfection, Immunity
Journal
Multiple Sclerosis and Related Disorders
Volume -, Issue -, Pages 102447
Publisher
Elsevier BV
Online
2020-08-10
DOI
10.1016/j.msard.2020.102447

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.